European Finance News

Northland Resources Inc. (OSL:NAUR) Northland Resources: Share Capital Changes

🕔1/6/2009 4:33:01 PM

Northland Resources Inc. (OSL:NAUR) In December 2008, Northland Resources Inc. granted an incentive stock option to purchase up to 200,000 shares exercisable at a price of $1.00 per share until March 31, 2009. In addition, existing stock options to purchase up to 100,000 shares of Northland expired unexercised on December 28, 2008.

Lesen Sie die komplette Artikel

Northland Resources Inc. (OSL:NAUR) Northland Resources: Mandatory Notification Of Trade

🕔1/6/2009 4:33:00 PM

Northland Resources Inc. (OSL:NAUR) Northland Resources Inc. has granted to Simon Jackson an incentive stock option to acquire up to 125,000 shares of Northland at a price of $0.61 per share. After this transaction, he holds Nil shares and 125,000 options in Northland.

Lesen Sie die komplette Artikel

Galapagos NV (EBR:GLPG) Galapagos Delivers Pre-clinical Candidate Drug In Alliance With Glaxosmithkline And Receives €7.6 Million In Milestone Payments

🕔1/6/2009 5:03:00 AM

Galapagos NV (EBR:GLPG) Mechelen, Belgium; 5 January 2009 - Galapagos NV (Euronext: GLPG) announced today that it has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline (GSK). Galapagos also reached milestones on other compounds in the alliance, triggering payments totaling €7.6 million to Galapagos. To date, Galapagos has earned a total of €25.5 million in payments from GSK under this alliance.

Lesen Sie die komplette Artikel

UCB (EBR:UCB) Receives Complete Response Letter From U.S. FDA For Use Of Cimzia® In Rheumatoid Arthritis Patients

🕔1/6/2009 4:21:00 AM

UCB (EBR:UCB) Brussels (Belgium), 5 January, 2009 at 6:00 pm CET - Press release - regulated information - UCB announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) relating to the Biologics License Application (BLA) of Cimzia® (certolizumab pegol), the first PEGylated anti-TNF, for the treatment of rheumatoid arthritis (RA).

Lesen Sie die komplette Artikel

Van Lanschot (AMS:VLAN) Completes Acquisition Of ING Private Banking Curaçao

🕔1/6/2009 4:01:00 AM

Van Lanschot (AMS:VLAN) Van Lanschot Bankiers (Curaçao) N.V. completed the acquisition of the private banking activities of ING Bank N.V. in Curaçao, Netherlands Antilles, on 31 December 2008. The acquisition was announced on 7 November 2008.

Lesen Sie die komplette Artikel

Solteq Oyj (HEL:STQ1V) SHARE REPURCHASE 5.1.2009

🕔1/6/2009 3:43:00 AM

Solteq Oyj (HEL:STQ1V) Solteq Plc ANNOUNCEMENT 5.1.2009

Lesen Sie die komplette Artikel

AMG Advanced Metallurgical Group N.V. (AMS:AMG) AMG Comments On The Impact Of The Current Global Slowdow

🕔1/6/2009 3:31:00 AM

AMG Advanced Metallurgical Group N.V. (AMS:AMG) Amsterdam, 5 January 2009 --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") expects lower than previously forecasted 2008 earnings due to the severe downturn of global economic activity and resulting lower sales volumes and decreased metals prices in the Advanced Materials Division. The significant drop in metal prices and lower sales volumes in the fourth quarter will result in inventory write downs of approximately $20 million. AMG is lowering its 2008 EBITDA target to $175 - $185 million or 47% - 55% growth over 2007.

Lesen Sie die komplette Artikel